Researchers at the University of California are recruiting participants for a first-of-its-kind study of essential tremor and the efficacy of cannabidiol … More
Patients with schizophrenia, whose current medication is not fully effective, will participate in a clinical trial to see if CBD is safe and effective when used alongside an anti-psychotic drug, according to a newly registered clinical trial.
First study shows how CBD acts on stomach-cancer cells
When paired with certain antibiotics, CBD significantly enhanced antibacterial effects.
Provides the first real world data (outside a clinical trial) on the dosing of THC:CBD in amyotrophic lateral sclerosis (ALS).
Some bacterial infections are becoming resistant to antibiotics. It turns out that CBD may be effective in the fight against dangerous infections.
Terpenes’ contribution to therapeutic effect of cannabinoids “may be significant.”
Synthetic THC combiner Obsessive Compulsive Disorder: A marked reduction in symptoms, according to new research out of the New York State Psychiatric Institute.
Researchers have discovered that cannabis is frequently used to alleviate diarrhea, abdominal pain, and loss of appetite caused by inflammatory bowel disease.
Several clinical trials are planned or underway to assess the effectiveness of THC and CBD in treating these conditions, such a Crohn’s and colitis.
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.”